Profile

James J. Urbanic, M.D.Wake Forest Baptist Health

James J. Urbanic, M.D.

Assistant Professor,

Clinical Specialties

Lung Cancer, Radiation Oncology, Radiosurgery, Brachytherapy, Breast Cancer

Contact Information

New Patient Appointments: 336-716-WAKE
Returning Patient Appointments: 336-713-3600
Department: 336-713-3600

Email: jurbanic@wakehealth.edu

Insurance Accepted »

Education & Training

  • M.D., Medical Univ Of South Carolina , 2003
  • B.S., US Merchant Marine Academy , 1992
  • Internship, Internal Medicine, Med U Sc Teaching Hosps, 2004
  • Residency, Radiation Oncology, North Carolina Baptist Hospita, 2007
  • Residency, Radiation Oncology, North Carolina Baptist Hospita, 2008

Memberships

  • Am Assn Of Cancer Research
  • Radiation Research Society
  • Am Medical Assn
  • Radiological Soc of North Amer
  • Am Soc Of Clinical Oncology
  • Am Soc Of Ther Rad & Oncology

NPI Number

  • 1164607875
James J. Urbanic, M.D.Wake Forest Baptist Health

James J. Urbanic, M.D.

Assistant Professor, Radiation Oncology
Comprehensive Cancer Center

Contact Information

Academic: 336-713-3600 | Department: 336-713-3600

Email: jurbanic@wakehealth.edu

Recent Publications

Kilburn JM, Ellis TL [deceased], Lovato JF, Urbanic JJ, Daniel Bourland J, Munley MT, Deguzman AF, McMullen KP, Shaw EG, Tatter SB, Chan MD. Local control and toxicity outcomes in brainstem metastases treated with single fraction radiosurgery: is there a volume threshold for toxicity?. J Neurooncol. 2014;117(1):167-174.

Ayala-Peacock DN, Blackstock AW, Kearns WT, Hinson WH, Munley MT, Miller AA, Petty WJ, Urbanic JJ. Stereotactic body radiation therapy (SBRT) and image guided accelerated hypofractionated radiation therapy (IGAHRT) for the treatment of oligometastatic cancers [abstract]. Int J Radiat Oncol Biol Phys. 2013;87(2 Suppl):S567-S568.

Garg S, Kilburn JM, Randolph DM, Lucas JT, Urbanic JJ, Porosnicu M, Hinson WH, Kearns WT, Greven KM. Re-irradiation for second primary or recurrent cancers of the head and neck: composite dosimetric measures to evaluate dose to the carotid arteries [abstract]. Int J Radiat Oncol Biol Phys. 2013;87(2 Suppl):S480-S481.

Kilburn JM, Lucas JT, Soike MH, Ayala-Peacock D, Blackstock AW, Kearns WT, Hinson WH, Miller AA, Petty WJ, Urbanic JJ. Is a clinical target volume (CTV) necessary in treatment of thoracic malignancies treated in the modern era combining 4-D imaging and image guided radiation therapy (IGRT)? [abstract]. Int J Radiat Oncol Biol Phys. 2013;87(2 Suppl):S549.

Kilburn JM, Lester SC, Lucas JT, Blackstock AW, Kearns WT, Hinson WH, Munley MT, Miller AA, Petty WJ, Urbanic JJ. Multiple courses of thoracic radiation therapy (XRT) using stereotactic body radiation therapy (SBRT) as the first or second course of treatment for tumors outside the original high-dose region [abstract]. Int J Radiat Oncol Biol Phys. 2013;87(2 Suppl):S36.

Lester SC, Kilburn JM, Lucas JT, Munley MT, Blackstock AW, Kearns WT, Hinson WH, Miller AA, Petty WJ, Urbanic JJ. Salvage radiation for mediastinal relapse after treatment with accelerated hypofractionated radiation therapy (AHRT) or stereotactic body radiation therapy (SBRT) for stage I/II NSCLC [abstract]. Int J Radiat Oncol Biol Phys. 2013;87(2 Suppl):S543-S544.

Lucas JT, Colmer HG, White GL, Isom SP, Ellis TL [deceased], Urbanic JJ, Tatter SB, Chan MD. A competing risk analysis of neurologic versus nonneurologic death in patients undergoing radiosurgical salvage following whole brain radiation therapy failure (WBRT): who actually dies of their brain metastases? [abstract]. Int J Radiat Oncol Biol Phys. 2013;87(2 Suppl):S52.

Soike M, Kilburn JM, Lucas JT, Ayala-Peacock D, Blackstock AW, Kearns WT, Hinson WH, Miller AT [sic] [Miller AA], Petty WJ, Urbanic JJ. Image guided radiation therapy results in mproved local control in lung cancer patients treated with fractionated radiation therapy for stage IIB-IIIB disease [abstract]. Int J Radiat Oncol Biol Phys. 2013;87(2 Suppl):S547-S548.

Videtic GM, Hu C, Singh A, Chang JY, Parker W, Olivier K, Schild S, Komaki R, Urbanic J, Choy H. Radiation Therapy Oncology Group (RTOG) protocol 0915: a randomized phase 2 study comparing 2 stereotactic body radiation therapy (SBRT) schedules for medically inoperable patients with stage I peripheral non-small cell lung cancer [abstract]. Int J Radiat Oncol Biol Phys. 2013;87(2 Suppl):S3.

Kuremsky JG, Urbanic JJ, Petty WJ, Lovato JF, Bourland JD, Tatter SB, Ellis TL [deceased], McMullen KP, Shaw EG, Chan MD. Tumor histology predicts patterns of failure and survival in patients with brain metastases from lung cancer treated with gamma knife radiosurgery. Neurosurgery. 2013;73(4):641-647.

Harris S, Chan MD, Lovato JF, Ellis TL, Tatter SB, Bourland JD, Munley MT, deGuzman AF, Shaw EG, Urbanic JJ, McMullen KP. Gamma knife stereotactic radiosurgery as salvage therapy after failure of whole-brain radiotherapy in patients with small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2012;83(1):e53-e59.

Cochran DC, Chan MD, Aklilu M, Lovato JF, Alphonse NK, Bourland JD, Urbanic JJ, McMullen KP, Shaw EG, Tatter SB, Ellis TL. The effect of targeted agents on outcomes in patients with brain metastases from renal cell carcinoma treated with Gamma Knife surgery. J Neurosurg. 2012;116(5):978-983.

Dougherty S, Urbanic J, Stewart J, Levine E, Howard-McNatt M. Is radiation indicated in patients with T1-T2 breast cancer with close or positive margins after mastectomy? [abstract]. Ann Surg Oncol. 2012;19(Suppl 1):S86-S87.

Vern-Gross TZ, Lawrence JA, Case LD, McMullen KP, Bourland JD, Metheny-Barlow LJ, Ellis TL [deceased], Tatter SB, Shaw EG, Urbanic JJ, Chan MD. Breast cancer subtype affects patterns of failure of brain metastases after treatment with stereotactic radiosurgery. J Neurooncol. 2012;110(3):381-388.

Loganathan AG, Chan MD, Alphonse N, Peiffer AM, Johnson AJ, McMullen KP, Urbanic JJ, Saconn PA, Bourland JD, Munley MT, Shaw EG, Tatter SB, Ellis TL [deceased]. Clinical outcomes of brain metastases treated with Gamma Knife radiosurgery with 3.0T versus 1.5T MRI-based treatment planning: have we finally optimised detection of occult brain metastases?. J Med Imaging Radiat Oncol. 2012;56(5):554-560.

Ayala-Peacock D, Peiffer AM, Ellis TL [deceased], Tatter SB, Urbanic JJ, Bourland JD, Shaw EG, Chan MC. Predictive factors for distant brain failure after primary radiosurgical management of brain metastases [abstract]. Int J Radiat Oncol Biol Phys. 2012;84(3 Suppl):S296.

Hampton CJ, Baydush A, Urbanic JJ. Is a single IGRT localization followed by a planned isocenter shift sufficient to accurately localize multi-isocenter SBRT targets? [abstract]. Int J Radiat Oncol Biol Phys. 2012;84(3 Suppl):S828.

Kilburn JM, Kuremsky JG, Blackstock AW, Kearns WT, Hampton CJ, Hinson WH, Miller AA, Petty WJ, Urbanic JJ. Thoracic reirradiation in patients with stereotactic body radiation therapy (SBRT) as first or second course of treatment [abstract]. Int J Radiat Oncol Biol Phys. 2012;84(3 Suppl):S604.

Kuremsky JG, Petty WJ, Miller A, Hinson WH, Hampton CJ, Blackstock AW, Urbanic JJ. Hypofractionated radiation therapy for stage I and II non-small cell lung cancer [abstract]. Int J Radiat Oncol Biol Phys. 2012;84(3 Suppl):S153-S154.

Urbanic JJ, Soike M, Hampton CJ, Lucas J, Hinson W, Kearns W, Blackstock AW. Long-term follow-up and patterns of failure for patients with medically inoperable stage I non-small cell lung cancer (NSCLC) treated with stereotactic body radiation therapy (SBRT) [abstract]. Int J Radiat Oncol Biol Phys. 2012;84(3 Suppl):S609.

Kilburn KM, Kuremsky JG, Blackstock AW, Kearns WT, Hampton CJ, Hinson WH, Miller AA, Petty WJ, Urbanic JJ. Thoracic re-irradiation in patients with stereotactic body radiotherapy (SBRT) as first or second course of treatment [abstract]. J Thorac Oncol. 2012;7(9 Suppl 4):S253-S254.

Kuremsky JG, Petty WJ, Miller A, HInson WH, Hampton CJ, Blackstock AW, Urbanic JJ. Hypofractionated radiotherapy for stage I and II non-small cell lung cancer [abstract]. J Thorac Oncol. 2012;7(9 Suppl 4):S230.

Lucas JT, Kuremsky JG, Soike M, Hinson W, Kearns WT, Hampton CJ, Blackstock AW, Urbanic JJ. Comparison of accelerated hypofractionation and stereotactic body radiotherapy for stage 1 & 2 non-small cell lung cancer (NSCLC) [abstract]. J Thorac Oncol. 2012;7(9 Suppl 4):S228.

Urbanic JJ, Soike M, Hampton CJ, Lucas J, Hinson W, Kearns W, Blackstock AW. Long-term follow-up and patterns of failure for patients with medically inoperable Stage I non-small cell lung cancer (NSCLC) treated with stereotactic body radiotherapy (SBRT) [abstract]. J Thorac Oncol. 2012;7(9 suppl 4):S288.

Jensen CA, Chan MD, McCoy TP, Bourland JD, deGuzman AF, Ellis TL, Ekstrand KE, McMullen KP, Munley MT, Shaw EG, Urbanic JJ, Tatter SB. Cavity-directed radiosurgery as adjuvant therapy after resection of a brain metastasis. J Neurosurg. 2011;114(6):1585-1591.

Lowell D, Tatter SB, Bourland JD, DeGuzman AF, Ekstrand KE, Ellis TL, Lovato JF, McMullen KP, Munley MT, Shaw EG, Urbanic JJ, Chan MD. Toxicity of gamma knife radiosurgery in the treatment of intracranial tumors in patients with collagen vascular diseases or multiple sclerosis. Int J Radiat Oncol Biol Phys. 2011;81(4):e519-e524.

Petty WJ, Voelzke WR, Urbanic JJ, Varela VA, Waller LL, Swift CB, Graham RM, Memoli VA, Dragnev KH. High cyclin D3 expression confers erlotinib resistance in aerodigestive tract cancer. Lung Cancer. 2011;74(3):384-391.

Petty WJ, Varela VA, Swift CB, Urbanic JJ. A role for angiotensin converting enzyme inhibition in lung cancer chemoprevention [abstract]. Int J Mol Med. 2011;28(Suppl 1):S68.

Kilburn JM, Ellis TL, Urbanic JJ, Bourland JD, Munley MT, deGuzman AF, McMullen KP, Shaw EG, Tatter SB, Chan MD. Outcomes for gamma knife radiosurgery for brainstem metastases [abstract]. Int J Radiat Oncol Biol Phys. 2011;81(2 Suppl):S302.

Kuremsky JG, Urbanic JJ, Petty WJ, Lovato JF, Bourland JD, Tatter SB, Ellis TL, McMullen KP, Shaw EG, Chan MD. Tumor histology predicts patterns of failure and survival in patients with lung cancer treated with gamma knife radiosurgery [abstract]. Int J Radiat Oncol Biol Phys. 2011;81(2 Suppl):S595.

Loganathan AG, Chan MD, Alphonse N, Peiffer AM, Johnson A, McMullen KP, Urbanic JJ, Saconn PA, Bourland JD, Munley MT, Shaw EG, Tatter SB, Ellis TL. Clinical outcomes of brain metastases treated with gamma knife radiosurgery with 3.0 T vs. 1.5 T MRI-based treatment planning [abstract]. Neuro Oncol. 2011;13(Suppl 3):129.

Vern-Gross TZ, McMullen KP, Case LD, Bourland JD, Ellis TL, Lawrence JA, Tatter SB, Shaw EG, Urbanic JJ, Chan MD. Patterns of failure in patients receiving gamma knife radiosurgery for breast carcinoma to the brain [abstract]. Int J Radiat Oncol Biol Phys. 2011;81(2 Suppl):S216-S217.

Vern-Gross TZ, McMullen KP, Case LD, Bourland JD, Ellis TL, Lawrence JA, Tatter SB, Shaw EG, Urbanic JJ, Chan MD. Patterns of failure in patients receiving gamma knife radiosurgery for breast carcinoma to the brain [abstract]. Neuro Oncol. 2011;13(Suppl 3):127.

McMullen KP, Harris S, Lovato J, Ellis TL, Tatter SB, Urbanic J, Bourland JD, Shaw EG, Chan MD. Salvage radiosurgery for patients with small cell lung cancer after previous whole brain radiations [abstract]. Int J Radiat Oncol Biol Phys. 2010;78(3 Suppl):S274-S275.

Lally BE, Geiger AM, Urbanic JJ, Butler JM, Wentworth S, Perry MC, Wilson LD, Horton JK, Detterbeck FC, Miller AA, Blackstock AW, et al. Trends in the outcomes for patients with limited stage small cell lung cancer: an analysis of the Surveillance, Epidemiology, and End Results database. Lung Cancer. 2009;64(2):226-231.

Lally BE, Urbanic JJ, Blackstock AW. Could it be that less is more? [editorial]. Lancet Oncol. 2009;10(5):435-437.

Urbanic JJ, Lally B, Blackstock AW. 'The best-laid plans ... often go awry ... ' [editorial]. J Thorac Oncol. 2009;4(7):783-784.

Hampton CJ, Kearns WT, Urbanic JJ, McMullen KP, Blackstock AW, Hinson WH. Impact of individualized target volumes on stereotactic body radiotherapy treatment planning (SBRT): volumetric analysis [abstract]. Int J Radiat Oncol Biol Phys. 2008;72(1 Suppl):S617.

Hampton CJ, Kearns WT, Urbanic JJ, McMullen KP, Blackstock AW, Hinson WH. Impact of individualized target volumes on stereotactic body radiotherapy treatment planning (SBRT): dosimetric analysis [abstract]. Int J Radiat Oncol Biol Phys. 2008;72(1 Suppl):S625-S626.

Kearns WT, Urbanic JJ, Hampton CJ, McMullen KP, Blackstock AW, Stieber VW, Hinson WH. Radiation safety issues with positron-emission/computed tomography simulation for stereotactic body radiation therapy. J Appl Clin Med Phys. 2008;9(3):141-146.

Urbanic JJ, McMullen KP, Stieber VW, Hinson WH, Kearns WT, Hampton CJ, Lovato JF, Livengood K, Rosdahl R, Blackstock AW. A phase I/II dose-escalation/efficacy study, of single fraction stereotactic body radiotherapy (SF-SBRT) for metastatic cancer [abstract]. Int J Radiat Oncol Biol Phys. 2008;72(1 Suppl):S140.

All Publications

For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.

For a list of earlier publications, visit the Carpenter Library Publication Search.

Assistant Professor, Radiation Oncology

Clinical Specialties

Lung Cancer, Radiation Oncology, Radiosurgery, Brachytherapy, Breast Cancer

Quick Reference

Request an Appointment
New Patients

336-716-WAKE
888-716-WAKE

Existing patients may contact the clinic directly.
Find a Doctor Ways to Give

Spotlight

Cancer Treatment with Stereotactic Ablative Radiotherapy

Cancer Treatment with Stereotactic Ablative Radiotherapy

James J. Urbanic, MD, a radiation oncologist, and Carnell J. Hampton, PhD, a physicist at the Comprehensive Cancer Center at Wake Forest Baptist Medical Center, use the most advanced linear accelerator to treat lung cancer.

USNWR 2013-2014Magnet Hospital RecognitionConsumer Choice2014 Best DoctorsJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.